Amedica, Mazor Robotics, InVivo Therapeutics & more: 18 key notes

Written by Anuja Vaidya | August 12, 2016 | Print  |

Here are 18 key notes on orthopedic and spine device companies over the past week.

Amedica's total product revenue was $4 million, a 16 percent decrease over the same period last year due to lower private label sales and weaker than expected commercial sales in key geographic regions.

 

Mazor CEO Ori Hadomi told analysts the company will start educating Medtronic sales representatives on Mazor X at training centers by late August.

 

Misonix recently entered into an exclusive partnership with SonoSpine to develop the next generation of ultrasonic technology.

 

Precision Spine plans to unveil its MD-Vue Lateral Access System at the North American Spine Society Annual Meeting in October in Boston.

 

Spine Wave commercially launched its Velocity L Expandable Interbody Device and the XLR II Lateral Access System.

 

Medicrea entered into agreements to raise €20 million, or $22.35 million, and has appointed Richard Kienzle as chief commercial officer and business development officer.

 

Misonix is supporting the Uganda Spine Surgery Mission for the fifth consecutive year.

 

Camber Spine Technologies and Joseph DiCicco, DO, of Orthopedic Trauma Associates of Southwestern Ohio, partnered to study the Prolix implant for sacroiliac joint fusion.

 

Stryker Performance Solutions, the business unit of Stryker's Reconstructive Division, is offering a new digital tool called Episode Performance Manager.

 

Medovex's CEO Jarrett Gorlin released a letter to its shareholders, outlining the company's achievements with the DenerveX System.

 

InVivo Therapeutics experienced a net loss of about $5.18 million, or $0.16 per diluted share, in the second quarter of 2016.

 

InVivo Therapeutics appointed Pamela Stahl to the position of chief commercial officer.

 

Greenville, N.C.-based Vidant Medical Center is serving as an INSPIRE study site, where InVivo Therapeutics will test its Neuro-Spinal Scaffold's efficacy and safety.

 

The FDA cleared DeGen Medical's CONNECT-L Transverse Connector.

 

Kuala Lumpur, Malaysia-based Pantai Medical Center researchers gathered early clinical study data on Lexington, Ky.-based Intralink-Spine's Réjuve System.

 

OrthoPediatrics signed a license agreement with Sydney Children's Hospitals Network in Australia for the EPIC Plate Physeal Tethering Technology.

 

Novastep entered into a service agreement with Academy Medical.

 

JRI Orthopaedics completed its acquisition of Sheffield Medical Products.

 

More articles on devices:
Flower Orthopedics launches the MTP Fusion Plate Portfolio: 3 things to know
NeuroMetrix's Quell Health Cloud gathered 1M+ hours of Quell therapy, health data: 5 key pointsNeuroMetrix's Quell Health Cloud gathered 1M+ hours of Quell therapy, health data: 5 key points
Corin Group, FX Solutions sign distribution agreement for US market: 4 points

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months